awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33426534-655DAA63-BE42-4278-8072-09886D36DA2B
Q33426534-655DAA63-BE42-4278-8072-09886D36DA2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33426534-655DAA63-BE42-4278-8072-09886D36DA2B
A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma
P2860
Q33426534-655DAA63-BE42-4278-8072-09886D36DA2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33426534-655DAA63-BE42-4278-8072-09886D36DA2B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b8bd214ddc2dfa970b6a84a940260b800f9945c
P2860
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo